General Information of Disease (ID: DISGTF4W)

Disease Name Histoplasmosis
Synonyms darling disease; Histoplasma caused disease or disorder; Histoplasma infectious disease; Histoplasma disease or disorder
Definition
A disease caused by the fungus Histoplasma capsulatum. It primarily affects the lungs but can also occur as a disseminated disease that affects additional organs. The acute respiratory disease has symptoms similar to those of a cold or flu and it usually resolves without treatment in healthy individuals. The disseminated form is generally fatal if untreated.
Disease Hierarchy
DISIP7GM: Primary systemic mycosis
DISEM33Q: Infectious disease
DISGTF4W: Histoplasmosis
Disease Identifiers
MONDO ID
MONDO_0018312
MESH ID
D006660
UMLS CUI
C0019655
MedGen ID
42468
HPO ID
HP:0032256
Orphanet ID
390
SNOMED CT ID
12962009

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)
This Disease is Treated as An Indication in 3 Approved Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
Amphotericin B DMTAJQE Approved Small molecular drug [1]
Itraconazole DMCR1MV Approved Small molecular drug [2]
Ketoconazole DMPZI3Q Approved Small molecular drug [3]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)
This Disease Is Related to 1 DTT Molecule(s)
Gene Name DTT ID Evidence Level Mode of Inheritance REF
ATP6V1A TTL2PXZ Strong Biomarker [4]
------------------------------------------------------------------------------------
This Disease Is Related to 2 DOT Molecule(s)
Gene Name DOT ID Evidence Level Mode of Inheritance REF
CIAO3 OT0V91PK Strong Biomarker [5]
RPS4X OTIH80EK Strong Biomarker [6]
------------------------------------------------------------------------------------

References

1 Amphotericin B FDA Label
2 Itraconazole FDA Label
3 Ketoconazole FDA Label
4 The Histoplasma capsulatum vacuolar ATPase is required for iron homeostasis, intracellular replication in macrophages and virulence in a murine model of histoplasmosis.Mol Microbiol. 2008 Oct;70(1):127-39. doi: 10.1111/j.1365-2958.2008.06395.x. Epub 2008 Aug 11.
5 PRN Ranibizumab in the Treatment of Choroidal Neovascularization Secondary to Ocular Histoplasmosis.Ophthalmic Surg Lasers Imaging Retina. 2018 Jan 1;49(1):20-26. doi: 10.3928/23258160-20171215-03.
6 Development of specific sequence-characterized amplified region markers for detecting Histoplasma capsulatum in clinical and environmental samples.J Clin Microbiol. 2012 Mar;50(3):673-9. doi: 10.1128/JCM.05271-11. Epub 2011 Dec 21.